Tim Petersen co-founded Arboretum Ventures in 2002 and focused his investments on transformative opportunities that disrupt healthcare sectors starved of technology or business model innovation. His investments have spanned various healthcare sectors, including healthcare information technology, medical device, and research instrumentation companies.
Examples of Tim’s successful companies include Inogen (Nasdaq: INGN) which revolutionized the delivery of oxygen to COPD patients, and Accuri Cytometers, which upended the billion-dollar flow cytometry sector (sold to Becton Dickinson).
He also led Arboretum’s investments into Hicuity Health, one of the nation’s largest acute care telemedicine solutions providers, and SI-BONE (Nasdaq: SIBN), which develops novel surgical products to treat SI Joint disfunction.
Other exited investments include health technology company HealthMedia (sold to Johnson & Johnson) and life science research instrumentation company Intellicyt (sold to Sartorius).
From 1999 to 2002, Tim worked for the Zell Lurie Institute for Entrepreneurial Studies at the University of Michigan, serving as its Managing Director. During his tenure at Michigan, he also directed the activities of the Wolverine Venture Fund, the Institute’s venture fund focused on early-stage life science and technology investments. Prior to Michigan, Tim was a manager in the investment banking practice at Plante Moran Corporate Finance and served as a management consultant at Industrial Economics, Inc.
Tim holds a BA in Economics from Williams College, an MS in Economics from the University of Wisconsin-Madison, and an MBA from the Ross School of Business at the University of Michigan. Tim is involved in a number of community efforts focused on venture capital and entrepreneurship and has served as Chairman of the Michigan Venture Capital Association.